Chemical Structure (Hydromorphone 01)
Hydromorphone Hydrochloride Injection, Solution
Product Images NDC 0409-3365
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Hydromorphone Hydrochloride (NDC 0409-3365). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Hydromorphone 02)
Image (Hydromorphone 03)
Image (Hydromorphone 04)
Image (Hydromorphone 05)
Image (Hydromorphone 06)
Image (Hydromorphone 07)
Image (Hydromorphone 08)
Image (Hydromorphone 09)
Principal Display Panel (1 mg/mL Ampule Label)
This is a single-use ampule of Hydrocodone HC injection, an opioid pain medication. Each ml of the injection contains 1 mg/ml. The product should be protected from light. The manufacturer is Hospira Inc., based in Lake Forest, IL, USA. The National Drug Code (NDC) for this product is 0409-2552-11. This is a prescription-only product.*
Principal Display Panel (1 mg/mL Ampule Box)
Principal Display Panel (2 mg/mL Ampule Label)
This is a description of a medication called Hydrocodone HCL. It comes in a single-use ampule of 1 mL with a strength of 2 mg/mL. It is an injection medication that is only available with a prescription. The drug should be protected from light, and it is manufactured by Hospira, Inc., based in Lake Forest, Illinois.*
Principal Display Panel (2 mg/mL Ampule Box)
This product is a single-use ampul for intravenous, intramuscular, or subcutaneous use. It should be stored at 20 to 25°C and protected from light. If the solution is discolored or contains a precipitate, it should not be used. The usual dosage can be found in the insert. There is a copy-free and unvarnished area for variable data including 2D barcode and GTIN. It is produced by Hospira.*
Principal Display Panel (4 mg/mL Ampule Label)
This is a prescription medication in the form of a single-use ampule containing 1 mL of Hydrocodone HC Injection, USP at a concentration of 4mg/mL. The medication should be protected from light. The manufacturer is Hospira, Inc located in Lake Forest, IL 60045 USA.*
Principal Display Panel (4 mg/mL Ampule Box)
Principal Display Panel (2 mg/mL Vial Label)
This is a description of a single-dose vial of HYDROmorphone HCI injection, USP. The vial contains 2 mg/mL of the medication and should be protected from light. The distributor of the vial is Hospira, Inc. based in Lake Forest, IL, USA. The remaining text might be the batch number and the expiration date.*
Principal Display Panel (2 mg/mL Vial Tray)
Principal Display Panel (1 mg/mL Cartridge Label)
This is a package of a single-dose Carpuject containing Hydrocodone HCI injection, USP with a dosage of 1mg/mL. The product is distributed by Hospira, headquartered in IL, USA. The package advises to protect from light and includes an expiration date. There is also mention of a "COPY FREE OVERLAP AREA" and a GS1 DataBar.*
Principal Display Panel (1 mg/mL Cartridge Carton)
This appears to be a label for a medication product containing hydrochloride. It includes some dosage information and precautions for storage and use. The product comes in 10-cartridge units with a luer lock, and a needle is not included. There is also a warning about not using the product if the solution is discolored or precipitated. The label appears to be intended for healthcare professionals and does not provide instructions or indications for use.*
Principal Display Panel (1 mg/mL Syringe Label)
The text is a label for a single-dose injection of HYDROmorphone HCI. The label includes information on dosage, lot number (#8888AA), and expiration date (DMMMYYYY). The label also includes instructions to protect the injection from light.*
Principal Display Panel (1 mg/mL Syringe Label)
Secure™ "Rxonly 1mL Single-dose Syringe with Luer Lock" containing "HYDROmorphone HCI Injection, USP 1 mg/mL" is an injection in a syringe. It protects the contents from light and is distributed by Hospira, Inc. The rest of the text includes some unreadable characters, and a lot number and expiration date are mentioned.*
Principal Display Panel (1 mg/mL Syringe Carton)
This is a description of a medication called "HYDROmorphone HCI Injection, USP" from Hospira. The medication is designed for intravenous, intramuscular, or subcutaneous use. The medication comes in single-dose prefilled syringes with a Luer Lock. The medication consists of a 1 mg/mL hydrochloride solution, and the package contains ten of the syringes, each with 1 mL of solution. The solution is stored at 20º to 25º Celsius and is adjusted for pH with citric acid or sodium hydroxide. The medication should be protected from light, and patients should not use it if the solution is discolored or contains a precipitate.*
Principal Display Panel (0.5 mL Syringe Label)
This is a label for a single-dose injection of HYDROmorphone HCI, with a strength of 0.5mg/0.5mL. It includes instructions to protect the content from light and an expiration date. The label also shows a copy-free area and a free overlap area. The NDC code for the injection is also visible.*
Principal Display Panel (0.5 mL Syringe Label)
This is a description of a single-dose syringe with Luer Lock, containing 0.5 mg/0.5 mL of HYDROmorphone HCI Injection, USP. It is for R x only and must be protected from light. The syringe can be opened by twisting it, and it was made by Hospira, Inc. The lot number and expiration date are provided on the packaging.*
Principal Display Panel (0.5 mL Syringe Carton)
This is a description of a prescription drug product containing HYDROmorphone HCI, for intravenous, intramuscular or subcutaneous use in 0.5mg/0.5mL Injection, USP. The product is manufactured by Hospira and includes Sterile Aqueous Injection in 10x05mL vials that are Luer Lock securely sealed. The dosage information can be found on the label. The package is designed to be stored in controlled temperatures and must not be used if the solution is discolored or contains a precipitate.*
Principal Display Panel (2 mg/mL Cartridge Label)
This is a description of a single-dose Carpuject sterile cartridge unit used to deliver Hydro-morphine HCI through a Luer Lock. It contains a warning to protect it from light and is distributed by Hospira, Inc in the United States. It also lists the product code, lot number and expiry date.*
Principal Display Panel (2 mg/mL Cartridge Carton)
Principal Display Panel (2 mg/mL Syringe Label)
Principal Display Panel (2 mg/mL Syringe Label)
This appears to be a label for a syringe containing Hydrocodone HCI, an injection used for pain relief. It is manufactured by Hospira, Inc. and contains 2 mg/mL of the drug. The label includes instructions to protect from light and also includes a barcode. The address of the manufacturer is listed as Lake Forest, IL, USA. No dosage or administration instructions are visible.*
Principal Display Panel (2 mg/mL Syringe Carton)
This is a description for a medication packaged in a single-dose prefilled syringe with a Luer Lock for intravenous, intramuscular, or subcutaneous use. The medication is a sterile, aqueous injection containing 2mg of hydromorphans hydrochloride and 5.4mg of sodium lactets with sodium chloride. The pH of the medication is adjusted with lactic acid or sodium hydroxide. The medication should be protected from light and should not be used if the solution is discolored or contains a precipitate. The usual dosage is not specified. The text also includes various identification codes (NDC codes).*
Principal Display Panel (4 mg/mL Cartridge Label)
This is a product label for a single-dose Carpuject™ containing hydro-morphone HCI injection, USP with a strength of 4 mg/mL. The product is sterile and comes in a cartridge unit with a Luer Lock. The label includes manufacturing details and usage instructions, including the drug's Rxonly nature and the need to protect the product from light. There is no indication what the product is used for.*
Principal Display Panel (4 mg/mL Cartridge Carton)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
